Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Computer Model Reveals Cancer's Energy Source

Published: Tuesday, August 19, 2014
Last Updated: Tuesday, August 19, 2014
Bookmark and Share
Findings focused on the energy-making process in cancer cells known as the Warburg Effect.

A computer model study reveals - for the first time - details of an energy-creating process vital and unique to cancer cells. The research holds promise for new interventions and for personalizing cancer treatments based on individual needs.

The findings, which will revise basic biochemistry textbooks, focused on the energy-making process in cancer cells known as the Warburg Effect.

The Cornell-led study, published July 9 in the journal eLife, revealed that some of the enzymes thought to have no effect on the Warburg Effect, in fact, play a large role: An enzyme called GAPDH influences many parts of a cancer cell’s energy-making pathway.

“Our findings open opportunities for new ways to intervene in the Warburg Effect,” said Jason Locasale, the paper’s senior author and assistant professor of nutritional sciences in Cornell’s College of Agricultural and Life Sciences. Alexander Shestov, a former senior research associate, and Xiaojing Liu, a postdoctoral fellow, both in Locasale’s lab, are the paper’s lead authors. The results also “provide glimpses into whether we have predictive capacity to discern if treatments might be working,” Locasale added.

All multicellular organisms evolved pathways that take nutrients, sugars and oxygen and make energy through respiration and chemical processes. In normal cells, this energy-making process is known as oxidative phosphorylation. But when cells evolve cancerous properties and grow uncontrollably, they instead ferment their sugars to create energy even in the presence of oxygen. This process is called aerobic glycolysis, or the Warburg Effect.

The new findings are an important step toward developing a drug that affects only fermentation and not the normal metabolism of glucose, thereby depriving cancer cells of energy. The new model lays groundwork for predicting whether treatments will be effective based on an individual’s unique metabolism.

Still, very few details have been known about the Warburg Effect. “We can now systematically perturb anything in the [computer] model and identify important components” of the Warburg Effect, Locasale said.

Dating back to work by Efraim Racker, a Cornell researcher who made seminal discoveries in the area in the 1970s, followed by advances in cancer and genetic research, it is “known now that almost every cancer gene has some capacity to induce the Warburg Effect,” making it fundamental to proliferative diseases, Locasale said.

Currently, the Warburg Effect is used in clinical practice to diagnose and monitor cancer. Doctors inject patients with radioactive glucose and then watch where it is consumed; tumors are a major source of consumption. Researchers are also exploring whether dietary interventions with less sugar and the use of diabetes drugs that lower glucose may impact the Warburg Effect to treat cancer.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tumor-suppressing Gene Lends Insight to Cancer Treatment
Researchers have found that delicate replication process derails if a gene named PTEN has mutated or is absent.
Tuesday, July 14, 2015
For Cancer Patients, Sugar-Coated Cells are Deadly
Paszek’s lab will focus on developing high-resolution microscopy to further study cell membrane-related cancer mechanisms.
Friday, June 27, 2014
Gold-Plated Nano-Bits Find, Destroy Cancer Cells
Scientists have merged tiny gold and iron oxide particles, then added antibody guides to steer them through the bloodstream toward colorectal cancer cells.
Monday, October 21, 2013
Genetic Switches Play Big Role in Human Evolution
Study offers further proof that the divergence of humans from chimpanzees was profoundly influenced by mutations to DNA sequences.
Wednesday, June 12, 2013
Turn out the Light: 'Switch' Determines Cancer Cell Fate
Like picking a career or a movie, cells have to make decisions – and cancer results from cells making wrong decisions.
Friday, May 03, 2013
Nano Compartments May Aid Drug Delivery, Catalyst Design
Spongelike nanoparticles whose pores can be filled with drugs offer the promise of drug delivery to specific targets in the body, avoiding unpleasant side effects.
Monday, April 22, 2013
Scientists Develop World's Smallest Drug Deliverer
Cornell researchers have created a pore in “Cornell Dots” – brightly glowing nanoparticles nicknamed C-Dots – that can carry medicine.
Friday, April 12, 2013
DNA Editor Named Runner-up Breakthrough of 2012
A discovery that allows life scientists to precisely edit genomes for everything from crop and livestock improvement to human gene and cell therapy was named runner-up for Science magazine's 2012 Breakthrough of the Year.
Wednesday, February 27, 2013
Organic Metamaterial Flows like a Liquid, Remembers its Shape
A bit reminiscent of the Terminator T-1000, a new material created by Cornell researchers is so soft that it can flow like a liquid and then, strangely, return to its original shape.
Tuesday, December 04, 2012
Study: How Cells form 'Trash Bags' for Recycling Waste
A class of membrane-sculpting proteins create vesicles that carry old and damaged proteins from the surface of cellular compartments into internal recycling plants where the waste is degraded and components are reused.
Tuesday, October 23, 2012
Metastatic 'Switch' Sheds New Light on Colon Cancer
What kills cancer patients often isn't the primary tumor; it's when the tumor metastasizes - or spreads the cancer to other areas of the body.
Tuesday, September 11, 2012
The Force is with us: GEDI Chip Sorts Prostate Cancer Cells
Geometrically Enhanced Differential Immunocapture chip identify and collect cancer cells from a patient's bloodstream.
Friday, June 29, 2012
Some Stem Cells Can Trigger Tumors
When in contact with even trace amounts of cancer cells, stem cells can create a microenvironment suitable for more tumors to grow.
Wednesday, June 06, 2012
Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos